… DC in a phase II clinical trial of patients with advanced stage IV … Adoptive cell therapy (ACT)
using autologous tumor-infiltrating … -1 reactive T cells and MART-1 pulsed DC vaccine versus …

… tumour lysate-dendritic cell vaccination is feasible and safe in patients with pancreatic
cancer… We previously demonstrated the potency of allogeneic lysate-dendritic cell (DC) …

… a phase II randomized study with adjuvant autologous tumor lysate-pulsed DC in resected
stage … Background: Adoptive cell therapy (ACT) is used successfully as a highly personalized …

… phase II clinical trial is designed to evaluate the safety and efficacy of immunization with specific
activated anti-HCC dendritic cells in … observed that the tumor lysate pulsed-DCs showed …

… DCs pulsed with autologous glioma tumor lysate in a Phase I/II trial … Phase I studies and
promising preliminary results, groups aimed to expand clinical trials in DCV into phase II studies …

… A prior phase II trial for GBM showed an expansion of CD8 + T-cells and cytotoxic T-…
our other tumor-lysed dendritic cell studies that reach response rates of up to 44%, this study’s …

… the pulsing of DCs with TAAs (as peptides or tumor lysate) … , with two studies being worthy
of note: a phase II trial which … , ICT-107 (autologous DCs pulsed with six synthetic peptide …

… with TAAs or tumor lysates and stimulated with standard … example, DCs pulsed with TAAs
from GBM stem cells provided … GBM enrolled in a Phase II clinical trial. Citation341 Similarly, …

… Adoptive cell therapy (ACT) with the transfer of ex vivo-expanded … Dendritic cells can be
generated in vitro from monocytes and pulsed with proteins, peptides or whole-tumor lysates or …

… (pts) were enrolled in this Phase 2 study, age ≥ 18, KPS ≥ 70… employed the use of total
tumor RNA (TTRNA)-pulsed DCs … for T cell activation in PBMC after adoptive cell therapy. We …